Ubs Group Ag Praxis Precision Medicines, Inc. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.83 - $1.18 $10,063 - $14,307	-12,125 Reduced 61.41%	7,620 $8,000
Q1 2023 May 12, 2023	BUY	$0.8 - $4.98 $7,592 - $47,260	9,490 Added 92.54%	19,745 $15,000
Q4 2022 Feb 08, 2023	BUY	$1.88 - $36.45 $19,279 - $373,794	10,255 New	10,255 $24,000
Q2 2022 Aug 10, 2022	BUY	$1.75 - $11.34 $148,380 - $961,507	84,789 Added 117.9%	156,707 $384,000
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $144,849 - $287,854	-14,187 Reduced 16.48%	71,918 $734,000
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $1.44 Million - $1.98 Million	86,050 Added 156454.55%	86,105 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $723 - $1,240	55 New	55 $1,000
Q1 2021 May 12, 2021	SELL	$29.34 - $60.2 $3.41 Million - $7.01 Million	-116,383 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$27.25 - $55.82 $3.17 Million - $6.5 Million	116,383 New	116,383 $6.4 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $2.62B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.